FLUORESCENT STEROID BINDING IN ENDOMETRIAL CARCINOMA

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$314,534.00
Award Year:
1990
Program:
SBIR
Phase:
Phase II
Contract:
n/a
Agency Tracking Number:
7918
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
Zeus Scientific Inc.
200 Evans Way, Branchburg, NJ, 08876
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
() -
Business Contact:
() -
Research Institution:
n/a
Abstract
TUMOR SAMPLES FROM WOMEN WITH ENDOMETRIAL CARCINOMA ARE RARELY ASSAYED FOR STEROID BINDING SITES ALTHOUGH IT IS COMMON KNOWLEDGE THAT THEY ARE OFTEN PROGESTIN-SENSITIVE. HORMONAL THERAPY, IF GIVEN, IS NEARLY ALWAYS ADMINISTERED ON AN EMPIRICAL BASIS. CONVENTIONAL BIOCHEMICAL ESTROGEN (ER) AND PROGESTERONE RECEPTOR (PGR) ASSAYS ARE VERY DIFFICULT TO PERFORM IN THIS MALIGNANCY SINCE SPECIMENS OFTEN CONTAIN ADMIXTURES OF BENIGN, HYPERPLASTIC AND MALIGNANT GLANDULAR ELEMENTS, STROMA AND MYOMETRIUM, ALL OF WHICH MAY CONTRIBUTE RECEPTOR TO A TUMOR CYTOSOL. THIS PROJECT PLANS TO STUDY INTACT TISSUE SECTIONS OF ENDOMETRIAL TUMOR TISSUE FOR ESTROGEN AND PROGESTERONE BINDING SITES USING FLUORESCEIN TAGGED STEROID CONJUGATES OFESTROGEN AND PROGESTERONE (FLUORO-CEP(R)) WHICH ALLOW FOR LOCALIZATION OF STEROID BINDING SITES AT A CELLULAR AND SUBCELLULAR LEVEL. EVENTUALLY, ASSAY RESULTS WILL BE CORRELATED WITH A VARIETY OF CLINICAL AND PATHOLOGICAL FEATURES INCLUDING AGE, MENOPAUSAL STATUS, TUMOR GRADE AND STAGE. IN THE PRESENT STUDY, RESULTS WILL ALSO BE CORRELATED WITH THOSE OF IMMUNOCYTOCHEMICAL ASSAYS EMPLOYINGMONOCLONAL ANTIBODIES TO ESTROGEN AND PROGESTERONE AND, WHERE SUFFICIENT TISSUE IS AVAILABLE, WITH RESULTS OF CONVENTIONAL BIOCHEMICAL ER AND PGR ASSAYS. THE ULTIMATE GOAL OF THESE STUDIES IS TO DEVELOP AN INEXPENSIVE METHOD TO ACCURATELY ASSAY FOR ENDOMETRIAL TUMOR STEROID BINDING SITES WHICH WILL HELP CLINICIANS IN THE SELECTION OFA MORE RATIONAL THERAPY FOR PATIENTS WITH ADVANCED CARCINOMA. THE ASSAY SHOULD BE CAPABLE OF PERFORMANCE IN THE AVERAGE COMMUNITY HOSPITAL PATHOLOGY LABORATORY. PHASE I OF THESE STUDIES WILL CONCERN ITSELF WITH A PRELIMINARY COMPARISON OF FLUORO-CEP(R) WITH OTHER HISTOCHEMICAL AND BIOCHEMICAL PROCEDURES FOR DETECTION OF ER AND PGR.

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government